CIK 0000749647 · Non-accelerated filer<br>Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521256615
- Phone
- (609) 896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,942
- in 2 filings
Net −$7,942. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-22 | Dentzer James E Director | Grant or award | +11,148 | $2.20 | $25K | 14,963 |
| 2026-05-22 | Braun Donald P Director | Grant or award | +5,011 | $2.20 | $11K | 9,319 |
| 2026-05-22 | Fritz Frederick J. Director | Grant or award | +10,330 | $2.20 | $23K | 14,097 |
| 2026-05-22 | Lindborg Stacy President and CEO | Grant or award | +1,491 | $2.20 | $3K | 3,642 |
| 2026-01-02 | Bragg Kimberly CFO | Grant or award · Stock Option (Right to Buy) | +9,050 | 9,050 | ||
| 2026-01-02 | Anwer Khursheed Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +15,736 | 15,736 | ||
| 2026-01-02 | Fritz Frederick J. Director | Grant or award · Stock Option (Right to Buy) | +5,892 | 5,892 | ||
| 2026-01-02 | Faller Douglas Vincent Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +12,667 | 12,667 | ||
| 2026-01-02 | Eylward Susan General Counsel and Corp Sec | Grant or award · Stock Option (Right to Buy) | +8,251 | 8,251 | ||
| 2026-01-02 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +4,827 | 4,827 | ||
| 2026-01-02 | Braun Donald P Director | Grant or award · Stock Option (Right to Buy) | +5,881 | 5,881 | ||
| 2026-01-02 | Dentzer James E Director | Grant or award · Stock Option (Right to Buy) | +4,405 | 4,405 | ||
| 2026-01-02 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +43,821 | 43,821 | ||
| 2026-01-02 | Lindborg Stacy President and CEO | Grant or award · Stock Option (Right to Buy) | +56,187 | 56,187 | ||
| 2025-09-06 | Lindborg Stacy President and CEO | Option exercise | +1,667 | 3,584 | ||
| 2025-09-06 | Lindborg Stacy President and CEO | Option exercise · Restricted Stock | −1,667 | 0 | ||
| 2025-08-04 | Dentzer James E Director | Grant or award | +3,318 | $9.20 | $31K | 3,318 |
| 2025-08-04 | Dentzer James E Director | Grant or award · Stock Option (Right to Buy) | +250 | 250 | ||
| 2025-08-04 | Pellizzari Christine A Director | Grant or award | +2,248 | $9.20 | $21K | 2,248 |
| 2025-08-04 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +250 | 250 |
Page 4 of 6 · 119 trades